Literature DB >> 18166607

Distinct MRI atrophy patterns in autopsy-proven Alzheimer's disease and frontotemporal lobar degeneration.

G D Rabinovici1, W W Seeley, E J Kim, M L Gorno-Tempini, K Rascovsky, T A Pagliaro, S C Allison, C Halabi, J H Kramer, J K Johnson, M W Weiner, M S Forman, J Q Trojanowski, S J Dearmond, B L Miller, H J Rosen.   

Abstract

To better define the anatomic distinctions between Alzheimer's disease (AD) and frontotemporal lobar degeneration (FTLD), we retrospectively applied voxel-based morphometry to the earliest magnetic resonance imaging scans of autopsy-proven AD (N = 11), FTLD (N = 18), and controls (N = 40). Compared with controls, AD patients showed gray matter reductions in posterior temporoparietal and occipital cortex; FTLD patients showed atrophy in medial prefrontal and medial temporal cortex, insula, hippocampus, and amygdala; and patients with both disorders showed atrophy in dorsolateral and orbital prefrontal cortex and lateral temporal cortex (P(FWE-corr) < .05). Compared with FTLD, AD patients had decreased gray matter in posterior parietal and occipital cortex, whereas FTLD patients had selective atrophy in anterior cingulate, frontal insula, subcallosal gyrus, and striatum (P < .001, uncorrected). These findings suggest that AD and FTLD are anatomically distinct, with degeneration of a posterior parietal network in AD and degeneration of a paralimbic fronto-insular-striatal network in FTLD.

Entities:  

Mesh:

Year:  2007        PMID: 18166607      PMCID: PMC2443731          DOI: 10.1177/1533317507308779

Source DB:  PubMed          Journal:  Am J Alzheimers Dis Other Demen        ISSN: 1533-3175            Impact factor:   2.035


  93 in total

1.  Topographical patterns of lobar atrophy in frontotemporal dementia and Alzheimer's disease.

Authors:  Christian Bocti; Conrad Rockel; Peter Roy; Fuqiang Gao; Sandra E Black
Journal:  Dement Geriatr Cogn Disord       Date:  2006-03-03       Impact factor: 2.959

Review 2.  Neural substrates of cognitive and behavioral deficits in atypical Alzheimer's disease.

Authors:  Armin von Gunten; Constantin Bouras; Enikö Kövari; Panteleimon Giannakopoulos; Patrick R Hof
Journal:  Brain Res Rev       Date:  2006-01-18

3.  Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis.

Authors:  Manuela Neumann; Deepak M Sampathu; Linda K Kwong; Adam C Truax; Matthew C Micsenyi; Thomas T Chou; Jennifer Bruce; Theresa Schuck; Murray Grossman; Christopher M Clark; Leo F McCluskey; Bruce L Miller; Eliezer Masliah; Ian R Mackenzie; Howard Feldman; Wolfgang Feiden; Hans A Kretzschmar; John Q Trojanowski; Virginia M-Y Lee
Journal:  Science       Date:  2006-10-06       Impact factor: 47.728

4.  Measurements of the amygdala and hippocampus in pathologically confirmed Alzheimer disease and frontotemporal lobar degeneration.

Authors:  Josephine Barnes; Jennifer L Whitwell; Chris Frost; Keith A Josephs; Martin Rossor; Nick C Fox
Journal:  Arch Neurol       Date:  2006-10

5.  Patterns of brain atrophy that differentiate corticobasal degeneration syndrome from progressive supranuclear palsy.

Authors:  Adam L Boxer; Michael D Geschwind; Nataliya Belfor; Maria Luisa Gorno-Tempini; Guido F Schauer; Bruce L Miller; Michael W Weiner; Howard J Rosen
Journal:  Arch Neurol       Date:  2006-01

6.  Patterns of atrophy in pathologically confirmed FTLD with and without motor neuron degeneration.

Authors:  Jennifer L Whitwell; Clifford R Jack; Matthew L Senjem; Keith A Josephs
Journal:  Neurology       Date:  2006-01-10       Impact factor: 9.910

7.  Frontotemporal dementia: clinicopathological correlations.

Authors:  Mark S Forman; Jennifer Farmer; Julene K Johnson; Christopher M Clark; Steven E Arnold; H Branch Coslett; Anjan Chatterjee; Howard I Hurtig; Jason H Karlawish; Howard J Rosen; Vivianna Van Deerlin; Virginia M-Y Lee; Bruce L Miller; John Q Trojanowski; Murray Grossman
Journal:  Ann Neurol       Date:  2006-06       Impact factor: 10.422

8.  Comparison of the diagnostic performance of FDG-PET and VBM-MRI in very mild Alzheimer's disease.

Authors:  Takashi Kawachi; Kazunari Ishii; Setsu Sakamoto; Masahiro Sasaki; Tetsuya Mori; Fumio Yamashita; Hiroshi Matsuda; Etsuro Mori
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-03-21       Impact factor: 9.236

Review 9.  Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium.

Authors:  I G McKeith; D W Dickson; J Lowe; M Emre; J T O'Brien; H Feldman; J Cummings; J E Duda; C Lippa; E K Perry; D Aarsland; H Arai; C G Ballard; B Boeve; D J Burn; D Costa; T Del Ser; B Dubois; D Galasko; S Gauthier; C G Goetz; E Gomez-Tortosa; G Halliday; L A Hansen; J Hardy; T Iwatsubo; R N Kalaria; D Kaufer; R A Kenny; A Korczyn; K Kosaka; V M Y Lee; A Lees; I Litvan; E Londos; O L Lopez; S Minoshima; Y Mizuno; J A Molina; E B Mukaetova-Ladinska; F Pasquier; R H Perry; J B Schulz; J Q Trojanowski; M Yamada
Journal:  Neurology       Date:  2005-10-19       Impact factor: 9.910

10.  Clinical and pathological characterization of progressive aphasia.

Authors:  Jonathan A Knibb; John H Xuereb; Karalyn Patterson; John R Hodges
Journal:  Ann Neurol       Date:  2006-01       Impact factor: 10.422

View more
  108 in total

Review 1.  Quantitative structural MRI for early detection of Alzheimer's disease.

Authors:  Linda K McEvoy; James B Brewer
Journal:  Expert Rev Neurother       Date:  2010-11       Impact factor: 4.618

2.  CSF metabolites in the differential diagnosis of Alzheimer's disease from frontal variant of frontotemporal dementia.

Authors:  Francesca de Rino; Filippo Martinelli-Boneschi; Francesca Caso; Marta Zuffi; Matteo Zabeo; Gabriella Passerini; Giancarlo Comi; Giuseppe Magnani; Massimo Franceschi
Journal:  Neurol Sci       Date:  2011-11-29       Impact factor: 3.307

Review 3.  Visual spatial cognition in neurodegenerative disease.

Authors:  Katherine L Possin
Journal:  Neurocase       Date:  2010-06-02       Impact factor: 0.881

4.  Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.

Authors:  Prashanthi Vemuri; Gyorgy Simon; Kejal Kantarci; Jennifer L Whitwell; Matthew L Senjem; Scott A Przybelski; Jeffrey L Gunter; Keith A Josephs; David S Knopman; Bradley F Boeve; Tanis J Ferman; Dennis W Dickson; Joseph E Parisi; Ronald C Petersen; Clifford R Jack
Journal:  Neuroimage       Date:  2010-12-31       Impact factor: 6.556

5.  The power of neuroimaging biomarkers for screening frontotemporal dementia.

Authors:  Corey T McMillan; Brian B Avants; Philip Cook; Lyle Ungar; John Q Trojanowski; Murray Grossman
Journal:  Hum Brain Mapp       Date:  2014-03-31       Impact factor: 5.038

6.  White matter imaging contributes to the multimodal diagnosis of frontotemporal lobar degeneration.

Authors:  C T McMillan; C Brun; S Siddiqui; M Churgin; D Libon; P Yushkevich; H Zhang; A Boller; J Gee; M Grossman
Journal:  Neurology       Date:  2012-05-16       Impact factor: 9.910

Review 7.  Clinical Neurology and Epidemiology of the Major Neurodegenerative Diseases.

Authors:  Michael G Erkkinen; Mee-Ohk Kim; Michael D Geschwind
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

8.  Sparse canonical correlation analysis relates network-level atrophy to multivariate cognitive measures in a neurodegenerative population.

Authors:  Brian B Avants; David J Libon; Katya Rascovsky; Ashley Boller; Corey T McMillan; Lauren Massimo; H Branch Coslett; Anjan Chatterjee; Rachel G Gross; Murray Grossman
Journal:  Neuroimage       Date:  2013-10-02       Impact factor: 6.556

9.  Dementia induces correlated reductions in white matter integrity and cortical thickness: a multivariate neuroimaging study with sparse canonical correlation analysis.

Authors:  Brian B Avants; Philip A Cook; Lyle Ungar; James C Gee; Murray Grossman
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

10.  Effect of leukocyte telomere length on total and regional brain volumes in a large population-based cohort.

Authors:  Kevin S King; Julia Kozlitina; Roger N Rosenberg; Ronald M Peshock; Roderick W McColl; Christine K Garcia
Journal:  JAMA Neurol       Date:  2014-10       Impact factor: 18.302

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.